Bristol Myers Squibb Partners with Anthropic to Boost Drug Discovery
Bristol Myers Squibb has partnered with Anthropic to deploy the Claude AI model across its workforce, aiming to expedite drug discovery and development.
More from this archive
MIND Achieves Milestone with Anthropic’s Cyber Verification Program
MIND has become the first data security company accepted into Anthropic's Cyber Verification Program, allowing enhanced AI capabilities…
Benchling Inference Launches to Transform Biotech R&D with AI
Benchling Inference, in collaboration with Baseten, offers biotech firms scalable AI capabilities to streamline drug discovery processes, addressing…
World Gold Council CEO Predicts Bitcoin’s Demise Amid Gold’s Resurgence
David Tait, CEO of the World Gold Council, claims Bitcoin is heading to zero, attributing his belief to…
Cerebras Challenges Nvidia’s AI Inference Dominance Amid Evolving Market Needs
While Nvidia maintains its grip on AI training, the rise of Cerebras highlights a shift in the inference…
The archive
sorted by latest
Anthropic Introduces Claude for Small Business with 15 Workflows
GPUBeat Desk · 2 min
Tenable Partners with Anthropic to Enhance AI Offerings
GPUBeat Desk · 2 min
Grey’s Anatomy Expands with New Spinoff Set in Texas
GPUBeat Desk · 2 min
Anthropic Strengthens Data Center Team with Latest Google Hire
GPUBeat Desk · 2 min
Noura Alqemzi’s Aimée Moreau: A Minimalist Approach to Luxury
GPUBeat Desk · 4 min